| Name | Title | Contact Details |
|---|
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 100,000 implanted to date.
Medical Management Specialists is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
LensGen™ is an ophthalmic medical device company developing an accommodating intraocular lens (AIOL) based solution to treat presbyopia and/or cataracts.
Apieron Biosystems is a Menlo Park, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Laboratorie Dentachrome is a Quebec, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.